An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India

• Suman Kanungo,

  Affiliation National Institute of Cholera and Enteric Diseases, Kolkata, India

  ⨯
• Sachin N. Desai ,

  * E-mail: sdesai@ivi.int

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Jayanta Saha,

  Affiliation National Institute of Cholera and Enteric Diseases, Kolkata, India

  ⨯
• Ranjan Kumar Nandy,

  Affiliation National Institute of Cholera and Enteric Diseases, Kolkata, India

  ⨯
• Anuradha Sinha,

  Affiliation National Institute of Cholera and Enteric Diseases, Kolkata, India

  ⨯
• Deok Ryun Kim,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Barnali Bannerjee,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Byomkesh Manna,

  Affiliation National Institute of Cholera and Enteric Diseases, Kolkata, India

  ⨯
• Jae Seung Yang,

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯
• Mohammad Ali,

  Affiliations National Institute of Cholera and Enteric Diseases, Kolkata, India, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Dipika Sur,

  Affiliations National Institute of Cholera and Enteric Diseases, Kolkata, India, PATH India Office, New Delhi, India

  ⨯
• Thomas F. Wierzba

  Affiliation International Vaccine Institute, Seoul, Republic of Korea

  ⨯